bepmed |

2011091411
l 2011
WO

6221. POLYESTERS, METHODS OF MAKING POLYESTERS AND USES THEREFOR

Abstract

Polyester compositions and functionalized polyester compositions are provided along with methods of making the compositions as well as methods of using the compositions, for example...

13:49 / methods

102133433
l 2011
CN

6222. Injectable cardiac muscular tissue engineering product and preparation method thereof

Abstract

The invention discloses an injectable cardiac muscular tissue engineering product based on a polysaccharide-polypeptide micro-sphere support and a preparation method thereof, which belong to the...

13:49 / rest

2011177590
l 2011
US

6223. Bioprinted Nanoparticles and Methods of Use

Abstract

The present invention provides compositions and methods that combine the initial patterning capabilities of a direct cell printing system with the active patterning capabilities of...

13:49 / cells / methods

2011177170
l 2011
US

6224. IMPLANTABLE NEUROENDOPROSTHETIC SYSTEM, A METHOD OF PRODUCTION THEREOF AND A METHOD OF RECONSTRUCTIVE NEUROSURGICAL OPERATION

Abstract

Intended for the use in neurosurgery and organ tissue engineering to replace defects of nervous tissue of a mammal brain and spinal cord (B&SC) in...

13:49 / cells / methods

2011125351
l 2011
JP

6225. SURFACE FOR CELL CULTURE

Abstract

PROBLEM TO BE SOLVED: To provide a substrate which may satisfy all necessary conditions for a vehicle ideal for culturing of cell/tissue and transfer to...

13:49 / cells / methods

2011189240
l 2011
US

6226. MICROENCAPSULATED COMPOSITIONS FOR ENDOLUMINAL TISSUE ENGINEERING

Abstract

A tissue engineering composition adapted for application to an interior surface of a body lumen of a patient. The composition comprises (a) a carrier medium...

13:49 / cells / methods

2011120595
l 2011
JP

6227. GROWTH FACTOR COMPLEX AND MODULATION OF CELL MIGRATION AND GROWTH

Abstract

PROBLEM TO BE SOLVED: To provide isolated protein complexes including a growth factor, e.g. insulin-like growth factor (IGF)-I, IGF-II, vascular endothelium growth factor (VEGF) or...

13:49 / growth factors / methods

102127507
l 2011
CN

6228. Biological tissue engineering vasculogenesis system

Abstract

The invention discloses a biological tissue engineering vasculogenesis system, which comprises a micro direct current speed-regulating motor, a cylindrical friction wheel drive system, a rotary...

13:49 / cells / system

102127238
l 2011
CN

6229. Method for preparing degradable polymer microspheres with controllable grain size

Abstract

The invention discloses a method for preparing degradable polymer microspheres with controllable grain size, and belongs to the field of functional materials. The method comprises...

13:49 / methods / Scaffolds

102124331
l 2011
CN

6230. Self-assembling multicellular bodies and methods of producing a three-dimensional biological structure using the same

Abstract

Structures and methods for tissue engineering include a multicellular body including a plurality of living cells. A plurality of multicellular bodies can be arranged in...

13:49 / cells / methods

Author: admin

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract